Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (IRELAnD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03574909
Recruitment Status : Not yet recruiting
First Posted : July 2, 2018
Last Update Posted : August 27, 2018
Health Research Board, Ireland
Information provided by (Responsible Party):
Royal College of Surgeons, Ireland

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021